Human UC-MSCs exosomes alleviate methionine/choline deficient diet-induced NASH in mice by regulating the anti-inflammatory phenotype of macrophages and by reversing PPARα protein expression in liver cells, revealing that human UC-MSCs-derived exosomes hold great potential in human MSCs-related NASH therapy. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.